Insiders / Mazumdar Claire

Mazumdar Claire

CIK 2034671personinsider
Companies
1
First seen
Feb 4, 2026
Last activity
Mar 20, 2026

Companies

CompanyRoleShares heldPeak heldTradesLatest
Bicara Therapeutics Inc. · BCAXCEO339,392450,00022

All securities held

2 positions · latest reported per filing
CompanySecuritySharesAs of
Bicara Therapeutics Inc.Common Stock339,392Mar 20, 2026
Bicara Therapeutics Inc.Stock Option (Right to Buy)Derivative176,107Mar 20, 2026

Activity

InsidersInstitutions
This person's insider trades (Form 4), across every company.
DateActionCompanyValueShares ΔPosition afterImpact
Mar 9, 2026SellBCAX
Bicara Therapeutics Inc.
Common Stock
$704.7K-37K
-9.77%
339,392
0.51% of shares
medium
Mar 9, 2026ExerciseBCAX
Bicara Therapeutics Inc.
Common Stock
$139.3K+37K
+10.83%
376,158
0.57% of shares
low
Mar 19, 2026SellBCAX
Bicara Therapeutics Inc.
Common Stock
$129.7K-7K
-1.99%
339,392
0.51% of shares
medium
Mar 18, 2026SellBCAX
Bicara Therapeutics Inc.
Common Stock
$122.4K-6K
-1.88%
339,392
0.51% of shares
medium
Mar 6, 2026SellBCAX
Bicara Therapeutics Inc.
Common Stock
$71.6K-4K
-1.11%
339,392
0.51% of shares
low
Mar 4, 2026SellBCAX
Bicara Therapeutics Inc.
Common Stock
$49.3K-3K
-0.77%
339,392
0.51% of shares
low
Mar 5, 2026SellBCAX
Bicara Therapeutics Inc.
Common Stock
$33.5K-2K
-0.52%
339,392
0.51% of shares
low
Mar 20, 2026SellBCAX
Bicara Therapeutics Inc.
Common Stock
$30.2K-2K
-0.47%
339,392
0.51% of shares
low
Mar 19, 2026ExerciseBCAX
Bicara Therapeutics Inc.
Common Stock
$26.2K+7K
+2.03%
346,297
0.52% of shares
low
Mar 18, 2026ExerciseBCAX
Bicara Therapeutics Inc.
Common Stock
$24.6K+6K
+1.91%
345,891
0.52% of shares
low